Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001213900-24-113155·INTRACOASTAL CAPITAL, LLC
Schedule 13G ownership disclosure
PHIO PHARMACEUTICALS CORP
Common stock, par value $0.0001 per share · CUSIP: 71880W501
Event date: 2024-12-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Mitchell P. Kopin
Shares: 90,987.00 · Class: 4.99%
- Daniel B. Asher
Shares: 90,987.00 · Class: 4.99%
- Intracoastal Capital LLC
Shares: 90,987.00 · Class: 4.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-113155
- Form type
- SCHEDULE 13G
- Filer
- INTRACOASTAL CAPITAL, LLC
- CIK
- CIK 1646799
- Filed
- Dec 27, 2024
- Reporting period
- Dec 19, 2024
- Description
- Schedule 13G beneficial ownership